Cryoport Executive and Leadership Team

Jerrell Shelton, the Chief Executive Officer at Cryoport, directs the overarching corporate strategy and long-term vision. Shelton guides the company's expansion into new markets and oversees the development of strategic partnerships crucial for advancing the life sciences supply chain. This leadership role involves ensuring Cryoport's operational framework aligns with its mission to provide unparalleled temperature-controlled logistics solutions. By focusing on sustainable growth and market leadership, Shelton drives the company's commitment to serving the biopharmaceutical, cell and gene therapy, and reproductive medicine sectors. The Chief Executive Officer's strategic direction ensures Cryoport maintains its position as a global leader in specialized logistics and advanced packaging solutions, supporting critical research and patient care worldwide. Jerrell Shelton's executive oversight is fundamental to the company's continued success and its impact on global health initiatives.

Mark Sawicki, the President & Chief Executive Officer at Cryoport, spearheads the company's operational execution and global expansion initiatives. Sawicki drives the integration of advanced packaging, specialty logistics, and biostorage services to meet the complex demands of the cell and gene therapy market. This executive leadership ensures seamless coordination across all operational facets, from cryogenic equipment manufacturing to informatics solutions. The President & Chief Executive Officer's focus on optimizing the supply chain for biopharmaceutical companies, research institutions, and government agencies worldwide solidifies Cryoport's market dominance. By fostering innovation and operational excellence, Mark Sawicki directly contributes to the company's ability to support critical life-saving treatments and advancements in human reproductive medicine. Sawicki's strategic management ensures the integrity and efficiency of Cryoport's temperature-controlled logistics network.

Phillip Wilson, the Chief Operating Officer at Cryoport, manages the day-to-day operations and ensures the efficient delivery of temperature-controlled supply chain solutions. Wilson oversees the global logistics network, focusing on enhancing service reliability and operational scalability for clients in the life sciences industry. This critical role involves optimizing processes for advanced packaging, specialty logistics, and biostorage services, particularly for the cell and gene therapy market. The Chief Operating Officer's leadership ensures that Cryoport's comprehensive platform effectively addresses the stringent requirements of biopharmaceutical companies, universities, and research institutions. By driving operational improvements and maintaining high service standards, Phillip Wilson directly supports the company's mission to safeguard sensitive biological materials throughout their journey. Wilson's operational expertise is key to Cryoport's reputation for excellence in specialized logistics.

Leonard Suelter, the Chief Technology Officer at Cryoport, directs the company's technological innovation and infrastructure development. Suelter oversees the creation and implementation of advanced informatics solutions and cryogenic equipment, enhancing the capabilities of Cryoport's temperature-controlled supply chain. This executive leadership ensures that the company leverages cutting-edge technology to meet the evolving needs of the life sciences industry, especially within the cell and gene therapy sector. The Chief Technology Officer's focus on technological advancement supports the secure and efficient transport of critical biological materials for biopharmaceutical companies, research institutions, and government agencies globally. By driving innovation in areas like cryogenic storage systems and logistics management, Leonard Suelter plays a pivotal role in maintaining Cryoport's competitive edge. Suelter's technological vision is integral to the company's mission of providing superior supply chain solutions.